News | Ultrasound Women's Health | January 30, 2019

FDA-approved breast ultrasound system provides radiation-free 3-D imaging for secondary screening

QTbreasthealth Opens New Breast Ultrasound Imaging Center in Grand Rapids

January 30, 2019 — QTbreasthealth launched a center in Grand Rapids, Mich., featuring its quantitative transmission ultrasound technology known as the QTscan. The U.S. Food and Drug Administration (FDA)-cleared 3-D ultrasound breast imaging technology provides women an option with no radiation, no compression and no injections. It also provides unimpeded visibility for women with dense breast tissue. QTbreasthealth’s goal is to provide technology that encourages women to get scanned as often as necessary, with no risk.

The Grand Rapids center is the third QTbreasthealth location, following two California locations in Marin and Walnut Creek, with several more locations scheduled to open around the country throughout 2019. News of the Grand Rapids opening comes on the heels of ongoing clinical trials, which have found the QTscan to be successful in identifying various types of breast tissue, particularly within dense breasts.

The new Grand Rapids center, like all QTbreasthealth locations, offers a spa-like breast imaging experience, complete with soothing scents, comforting robes and a relaxing imaging scan that some women actually sleep through. Unlike most other breast imaging centers, QTbreasthealth patients receive results via phone or teleconference with a provider within 72 hours.

Because the QTscan uses no radiation, the exam is available to women of all ages and avoids the frequency limits associated with radiation-based imaging tests. The clear and comprehensive, 3-D image delivered by the QTscan also makes QTbreasthealth an ideal second opinion for breast imaging, providing a more detailed image than mammography or handheld ultrasound.

For more information: www.qtultrasound.com


Related Content

News | Breast Biopsy Systems

Feb. 18, 2026 — Mammotome, a Danaher company, has introduced the Mammotome Prima MR Dual Vacuum-Assisted Breast Biopsy ...

Time February 18, 2026
arrow
News | Breast Imaging

Feb. 16, 2026 — Rising demand for breast cancer screening and diagnostics is outpacing the supply of available breast ...

Time February 17, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Feb. 5, 2026 — Eyas Medical Imaging, Inc. has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its ...

Time February 06, 2026
arrow
News | Ultrasound Women's Health

Feb. 5, 2026 — BrightHeart, a global provider of AI-driven prenatal ultrasound, has announced the availability of its B ...

Time February 05, 2026
arrow
News | Radiation Therapy

Feb. 4, 2026 — On World Cancer Day (02.04.26), the American Society for Radiation Oncology (ASTRO) and the European ...

Time February 04, 2026
arrow
News | Radiology Imaging

Feb. 4, 2026 — The Royal College of Radiologists (RCR) has issued its initial reaction to the British government's ...

Time February 04, 2026
arrow
News | FDA

Feb. 2, 2026 — Imagion Biosystems, Ltd. has submitted an Investigational New Drug (IND) application with the U.S. Food ...

Time February 02, 2026
arrow
News | Breast Imaging | Washington University

Jan. 22, 2026 — In breast cancer, a biopsy is the only diagnostic procedure that can determine if a suspicious lump or ...

Time January 29, 2026
arrow
News | Radiation Oncology

Jan. 27, 2026 — Researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with other leading ...

Time January 29, 2026
arrow
News | Radiology Education

Jan. 22, 2026—The American Roentgen Ray Society (ARRS) will host a live virtual symposium, "Medical Imaging for ...

Time January 28, 2026
arrow
Subscribe Now